# Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

> **NCT06170463** · PHASE1 · COMPLETED · sponsor: **Zagazig University** · enrollment: 210 (actual)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

## Interventions

- **DRUG:** Metformin Hydrochloride
- **DRUG:** MI/DCI combination in 40:1 ratio
- **DRUG:** Combination of Metformin hydrochloride and MI/DCI

## Key facts

- **NCT ID:** NCT06170463
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-04-15
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06170463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06170463, "Insulin Sensitizers Role in Control of PCOS Vicious Cycle.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06170463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*